首页> 美国卫生研究院文献>Disease Markers >Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients

【2h】

Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients

机译：中国青年患者可溶性尿激酶纤溶酶原激活物受体与冠状动脉疾病的风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Soluble urokinase plasminogen activator receptor (suPAR) is a novel marker of chronic inflammation and is considered to be a risk factor for coronary artery disease (CAD) in Caucasians. This study investigated the role of suPAR in young Chinese patients with CAD.

机译：背景技术可溶性尿激酶纤溶酶原激活物受体（suPAR）是慢性炎症的新型标志物，被认为是高加索人冠状动脉疾病（CAD）的危险因素。这项研究调查了suPAR在中国年轻的CAD患者中的作用。

著录项

期刊名称 Disease Markers
作者
Yuli Huang; Haobin Zhou; Yu Wu; You Yang; Wensheng Li; Jianhua Lu; Yunzhao Hu;
展开▼
作者单位

展开▼
年(卷),期 2017(2017),-1
年度 2017
页码 4719403
总页数 6
原文格式 PDF
正文语种
中图分类遗传学;应用微生物学;医学史;病理学;
关键词

相似文献

外文文献
中文文献
专利

1. Soluble urokinase plasminogen activator receptor : A risk factor for carotid plaque, stroke, and coronary artery disease [J] . PerssonM., 脰stlingG., SmithG., Stroke: A Journal of Cerebral Circulation . 2014,第1期

机译：可溶性尿激酶纤溶酶原激活物受体：颈动脉斑块，中风和冠状动脉疾病的危险因素
2. Soluble Urokinase Plasminogen Activator Receptor is Associated with Coronary Artery Calcification and Cardiovascular Disease in Patients Undergoing Hemodialysis [J] . Wu W., Cui Y., Hu J., Kidney and blood pressure research . 2018,第3期

机译：可溶性尿激酶纤溶酶原激活物受体与接受血液透析的患者冠状动脉钙化和心血管疾病相关
3. Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events [J] . Aristea Velegraki, Arshed A. Quyyumi, Christian W. Thorball, Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease . 2014,第4期

机译：可溶性尿激酶纤溶酶原激活物受体水平是冠状动脉疾病的存在和严重程度以及未来不良事件的独立预测因子
4. Plasminogen Activator Inhibitor I (PAI-I) -675 5G/4G Polymorphism in Patients with Coronary Artery Disease [C] . G. Apergis, M. Belia, A. Bratsas, International Congress on Thrombosis . 2004

机译：冠状动脉疾病患者的纤溶酶原激活剂抑制剂I（PAI-I）-675 5G / 4G多态性
5. A comparison of selected preoperative coronary artery disease risk factors in patients 40 years or younger and patients over 40 years undergoing coronary artery bypass graft surgery. [D] . Frye, Laurie Perry. 2002

机译：比较40岁以下的患者和40岁以上进行冠状动脉搭桥术的患者的术前选择的冠心病危险因素。
6. Cardio‐Renal Biomarker Soluble Urokinase‐Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin C‐Reactive Protein and Renal Function [O] . Julius Nikorowitsch, Tim Borchardt, Sebastian Appelbaum, 2020

机译：心肌肾脏生物标志物可溶性尿激酶型纤溶酶原激活因子与冠状动脉疾病患者无关的心血管死亡和心肌梗死与肌钙蛋白C反应蛋白和肾功能无关
7. Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients [O] . Yuli Huang, Haobin Zhou, Yu Wu, 2017

机译：溶于尿激酶纤溶酶原激活因子和年轻患者冠状动脉疾病的风险

Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients

摘要

著录项

相似文献

相关主题

期刊订阅